These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3008292)

  • 21. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental myasthenia gravis: isolation and quantitative assay of anti-acetylcholine receptor antibody protein concentration in sera of rabbits immunized with Narke acetylcholine receptor.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Exp Neurol; 1980 Jun; 68(3):512-20. PubMed ID: 7379895
    [No Abstract]   [Full Text] [Related]  

  • 24. Is experimental autoimmune myasthenia gravis induced only by acetylcholine receptors?
    Claudio TR; Raftery MA
    J Immunol; 1980 Mar; 124(3):1130-40. PubMed ID: 6153670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of hybridomas to analyse autoimmunity.
    Isenberg DA; Shoenfeld Y; Schwartz RS
    Br Med Bull; 1984 Jul; 40(3):262-6. PubMed ID: 6380637
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
    Lindstrom J; Einarson B
    Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
    Lindstrom J
    Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
    [No Abstract]   [Full Text] [Related]  

  • 29. Antireceptor or antihormone autoimmunity and its relationship with the idiotype network.
    Bach JF
    Adv Nephrol Necker Hosp; 1987; 16():251-80. PubMed ID: 3028089
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
    Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
    Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agrin-induced aggregation of acetylcholine receptors in muscles of rats with experimental autoimmune myasthenia gravis.
    Rimer M
    Ann N Y Acad Sci; 1998 May; 841():546-9. PubMed ID: 9668292
    [No Abstract]   [Full Text] [Related]  

  • 34. A role of alpha-fetoprotein in autoimmune diseases.
    Abramsky O; Brenner T
    Ann N Y Acad Sci; 1983; 417():108-16. PubMed ID: 6200026
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-receptor antibodies.
    Kirkness EF; Venter JC
    Curr Opin Immunol; 1989 Apr; 1(4):679-83. PubMed ID: 2553065
    [No Abstract]   [Full Text] [Related]  

  • 37. Myasthenia gravis.
    Sen S; Banerjee TK
    J Assoc Physicians India; 1995 Jul; 43(7):487-93. PubMed ID: 8713224
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis.
    de la Porte S; Ragueh F; Eymard B; Courbin P; Chapron J; Koenig J
    J Neurol Sci; 1993 Jul; 117(1-2):92-102. PubMed ID: 8410074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.